1. $BIIB Biotech: ‘Unprecedented Times,’ Not a Bubble http://blogs.barrons.com/stockstowatchtoday/2015/03/27/biotech-unprecedented-times-not-a-bubble/?mod=yahoobarrons&ru=yahoo

  2. Mega Biotech: Risk per Option Market - 1 $VRTX 2 $ILMN 5 $BIIB 7 $REGN Do It Yourself --> http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Pharmaceuticals,+Biotechnology+and+Life+Sciences|&x=Equal+Spaced&y=30-Day+Implied+Volatility&minMarketCap=24998&maxMarketCap=1000000&minRevenue=0&maxRevenue=1000000

  3. $BIIB vs. $REGN vs. $AMGN vs. $CELG Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=BIIB|REGN|AMGN|CELG|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  4. $celg $biib $cytx $nlnk $REGN $oncy $vblt ok traders, who s gonna pounce on XBIO on ipo day?

  5. Leading growth deteriorating quickly. Correction looms again. http://capitalistbull.blogspot.tw/p/leading-stocks-analysis.html -- $SPY $QQQ $BIIB $CNC $AAPL $AVGO $NXPI $MANH

  6. $BIIB vs. $ALXN vs. $AMGN vs. $GILD Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=BIIB|ALXN|AMGN|GILD|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  7. @OphirGottlieb $BIIB EPS is Accelerating. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=BIIB&financial_bar=EPS+-+Net(Diluted)+TTM+&financial_line=EPS+-+Net(Diluted)+TTM+&start_date=03/31/2000&end_date=12/31/2014&show_line=false&sk=6707cd40e7f4b3c95fa28e5d22b3a8af

  8. $BIIB EPS is Accelerating. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=BIIB&financial_bar=EPS+-+Net(Diluted)+TTM+&financial_line=EPS+-+Net(Diluted)+TTM+&start_date=03/31/2000&end_date=12/31/2014&show_line=false&sk=6707cd40e7f4b3c95fa28e5d22b3a8af

  9. $BIIB vs. $ALXN vs. $REGN vs. $GILD Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=BIIB|ALXN|REGN|GILD|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  10. $BIIB vs. $ALXN vs. $GILD vs. $CELG Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=BIIB|ALXN|GILD|CELG|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. $BIIB Assets are Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=BIIB&financial_bar=Assets+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=03/31/2000&end_date=12/31/2014&show_line=false&sk=6707cd40e7f4b3c95fa28e5d22b3a8af

  12. $SYN excitement in MS today comes from new, oral drugs - $BIIB & Tecfidera. Since Trimesta administered orally too, I think $BIIB a suitor.

  13. William O neil detailed many sell signals in HTMMIS. $BIIB flashed sell signal on biggest rise of the move. Hindsight

  14. $BIIB Revenue is Growing. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=BIIB&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=03/31/2000&end_date=12/31/2014&show_line=false&sk=6707cd40e7f4b3c95fa28e5d22b3a8af

  15. $BIIB dead cat bounce

  16. $BIIB why did biib and gild stock price fall apart toward end of day?

  17. Doji Stocks http://www.dailystockplays.com/Doji-Stocks-2015-03-27.html $PBR $EPI $GLD $LLY $SBUX $NPBC $PLD $AGNC $VNQ $CVC $JCI $BIIB $FTI $LYG $OHI $AFL $CHRW $MPW $KERX

  18. Biotech bubble? --> ...we are also seeing unprecedented success...that is fundamental and long-lasting http://www.marketwatch.com/story/biotech-bubble-may-just-be-an-optical-illusion-2015-03-27?siteid=yhoof2 $GILD $BIIB

  19. $BIIB R&D Now Over Half a Billion --> http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=BIIB&financial_bar=Research+and+Development+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=01/01/2000&end_date=03/31/2015&show_line=false&sk=2833919c916b79fddf3c71bbb3b757f9

  20. $BIIB.. In my top 3 of Biotechs. Up 0.42% and I will convince myself it will break MAs back up.. .Right? :-/ http://lite.capitalmarketlabs.com/cmld3b/stock_biib.php

  21. @OphirGottlieb Biotech/Pharma: Revenue per Employee - 1 $GILD 2 $BIIB 3 $CELG 4 $PCYC 7 $REGN Chart -> http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Pharmaceuticals,+Biotechnology+and+Life+Sciences|&x=Equal+Spaced&y=Revenue/Number+of+Employees+(TTM+US$+Millions)&minMarketCap=15000&maxMarketCap=1000000&minRevenue=0&maxRevenue=1000000 absurd.

  22. Biotech/Pharma: Revenue per Employee - 1 $GILD 2 $BIIB 3 $CELG 4 $PCYC 7 $REGN Chart -> http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Pharmaceuticals,+Biotechnology+and+Life+Sciences|&x=Equal+Spaced&y=Revenue/Number+of+Employees+(TTM+US$+Millions)&minMarketCap=15000&maxMarketCap=1000000&minRevenue=0&maxRevenue=1000000

  23. @TraderX82: $BIIB Tons more downside to 400. It will hit it soon,riding this puppy down. No sweat. Another leg down nxt wk. Swoosh

  24. $BIIB well that sucked almost all our gains taken off today. Was up 1.4% at times

  25. $BIIB: New SEC Filing for BIIB: Form 8-K, No. 0000875045-15-000008 http://stocknewsflow.com/875045_000087504515000008_0000875045-15-000008